Your leading voice in digital health news
Twitter X Logo

Volpara partners with Microsoft to identify potential arteriosclerosis in women

28 June 2022
Pulse+IT

ASX-listed New Zealand firm Volpara Health is collaborating with Microsoft on a new R&D project looking at using Volpara’s mammogram software to potentially identify cardiovascular issues.

Volpara recently won a patent for its breast arterial calcifications (BACs) technology. BACs are often observed through screening mammography but while they are not thought to be allied to increased breast cancer risk, they may be indicative of arteriosclerosis.

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Copyright © 2024 Pulse IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down